查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585654

生物製药生物分离系统市场：按类型、最终用户划分 - 全球预测 2025-2030 年

Biopharmaceutical Bioseparation Systems Market by Type (Cell Disruption Technology, Centrifuges Technology, Chromatography Technique), End-user (Biopharmaceutical Companies, Research Institutes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物製药生物分离系统市场价值为151亿美元，预计到2024年将达到164.8亿美元，复合年增长率为9.49%，到2030年达到284.9亿美元。

生物製药生物分离系统包括用于从生物基质中分离和精製生物分子（例如蛋白质、核酸和细胞）的多种技术和方法。这些系统对于生产高纯度生物药品和确保治疗的安全性、有效性和品质至关重要。对生技药品、个人化医疗和基因疗法不断增长的需求强调了对这些系统的需求。生物分离系统应用于各种过程，例如过滤、离心、层析法和电泳。最终用途范围涵盖生物製药製造、学术研究和临床诊断等产业。主要成长动力包括生物技术的进步、生技药品研发投资的增加以及严格的纯度和品质监管标准。慢性病发病率的增加和对高效治疗药物的需求进一步推动了市场的扩张。

主要市场统计
基准年[2023] 151亿美元
预测年份 [2024] 164.8亿美元
预测年份 [2030] 284.9亿美元
复合年增长率（%） 9.49%

市场洞察揭示了开发高容量、经济高效且环境永续的生物分离系统的潜在机会。公司可以透过投资自动化数位化来提高流程效率和资料整合能力来实现成长。然而，高营运成本、技术复杂性和监管合规障碍等挑战可能会阻碍成长。供应链中断和缺乏熟练的专业人员也是主要障碍。为了克服这些障碍，该行业可以探索知识交流和能力建设的伙伴关係和协作。一次性技术、连续处理以及将人工智慧和机器学习整合到生物分离中的创新提供了有前景的成长领域。此外，解决生产中的可扩展性问题将培养未来的市场潜力。市场的动态特征是快速的技术进步和不断变化的消费者需求，需要在产品开拓和经营模式方面采取敏捷的策略和积极的创新。随着个人化医疗变得越来越普遍，专注于小规模、灵活的生物分离解决方案可能为寻求占领新兴细分市场的公司提供利润丰厚的机会。

市场动态：快速发展的生物製药生物分离系统市场的关键市场洞察

供需的动态交互作用正在改变生物製药生物分离系统市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对生物製药和个人化药物的需求不断增加
    • 政府支持国内医药产业的倡议
    • 标靶治疗的日益普及和重要性
  • 市场限制因素
    • 生物分离设备初始投资及营运成本较高
  • 市场机会
    • 增加对生物分离公司和技术的投资
    • 生物製药分离技术不断进步
  • 市场挑战
    • 监管挑战和复杂的检验流程

波特五力：驾驭生物製药生物分离系统市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物製药生物分离系统市场的外部影响

外部宏观环境因素在塑造生物製药生物分离系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析了解生物製药生物分离系统市场的竞争格局

生物製药生物分离系统市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵生物製药生物分离系统市场供应商的绩效评估

FPNV定位矩阵是评估生物製药生物分离系统市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划生物製药生物分离系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对生物製药生物分离系统市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对生物製药和个人化药物的需求增加
      • 政府支持国内医药产业的倡议
      • 标靶治疗的日益普及和重要性
    • 抑制因素
      • 生物分离设备的初期投资和运作成本较高。
    • 机会
      • 增加对生物分离公司和技术的投资
      • 生物製药分离技术的进展
    • 任务
      • 监管挑战和复杂的检验流程
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物製药生物分离系统市场：依类型

  • 细胞破坏技术
  • 离心机技术
  • 层析法技术
  • 电泳
  • 萃取技术
  • 过滤技术
  • 基于膜的
  • 沉淀

第七章生物製药生物分离系统市场：依最终用户分类

  • 生物製药公司
  • 调查机构

第八章北美和南美生物製药生物分离系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太生物製药生物分离系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲/中东/非洲生物製药生物分离系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • Agilent Technologies, Inc.
  • Alfa Wassermann, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Astrea Bioseparations Limited
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Flottweg SE
  • GEA Group Aktiengesellschaft
  • GL Sciences Inc.
  • Hitachi High-Tech Corporation.
  • Jasco Pty Ltd.
  • KNAUER Wissenschaftliche Gerate GmbH
  • Merck KGaA
  • Novasep Holding SAS
  • PerkinElmer Inc.
  • Repligen Corporation
  • Restek Corporation
  • Sartorius AG
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience LLC
  • Waters Corporation
  • YMC Co., Ltd.
Product Code: MRR-521BAA36EA6F

The Biopharmaceutical Bioseparation Systems Market was valued at USD 15.10 billion in 2023, expected to reach USD 16.48 billion in 2024, and is projected to grow at a CAGR of 9.49%, to USD 28.49 billion by 2030.

Biopharmaceutical bioseparation systems encompass a range of technologies and methodologies used to isolate and purify biomolecules such as proteins, nucleic acids, and cells from biological matrices. These systems are critical in producing high-purity biopharmaceuticals, ensuring the safety, efficacy, and quality of therapeutic products. The necessity of these systems is underscored by the growing demand for biologics, personalized medicine, and gene therapies. Bioseparation systems are applied in various processes including filtration, centrifugation, chromatography, and electrophoresis. The end-use scope spans industries such as biopharmaceutical manufacturing, academic research, and clinical diagnostics. Key growth drivers include advancements in biotech, increasing investment in biologics R&D, and stringent regulatory standards for purity and quality. The rise in chronic diseases and demand for efficient therapeutics further fuels market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 15.10 billion
Estimated Year [2024] USD 16.48 billion
Forecast Year [2030] USD 28.49 billion
CAGR (%) 9.49%

Market insights reveal potential opportunities in developing high-capacity, cost-effective, and environmentally sustainable bioseparation systems. Companies can seize growth by investing in automation and digitalization, enhancing process efficiency and data integration capabilities. However, challenges such as high operational costs, technical complexities, and regulatory compliance hurdles may impede growth. Supply chain disruptions and a shortage of skilled professionals also present significant obstacles. To overcome these barriers, the industry can explore partnerships and collaborations for knowledge exchange and capacity building. Innovations in single-use technologies, continuous processing, and integration of AI and machine learning into bioseparation offer promising areas for growth. Furthermore, addressing scalability issues in production can drive future market potential. The market's dynamic nature is characterized by rapid technological advancements and shifting consumer demands, necessitating agile strategies and proactive innovation in product development and business models. As personalized medicine gains traction, focusing on smaller-scale, flexible bioseparation solutions may present lucrative opportunities for businesses aiming to capture emerging segments.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Bioseparation Systems Market

The Biopharmaceutical Bioseparation Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for biopharmaceuticals and personalized medicines
    • Government initiatives to boost domestic pharmaceutical industry
    • Growing popularity and importance of targeted therapies
  • Market Restraints
    • High initial investments and operating costs of bioseparation equipment
  • Market Opportunities
    • Growing investments in bioseparation companies and technologies
    • Rising advancements in biopharmaceutical separation technologies
  • Market Challenges
    • Regulatory challenges and complex validation processes

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Bioseparation Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Bioseparation Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Bioseparation Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Bioseparation Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Bioseparation Systems Market

A detailed market share analysis in the Biopharmaceutical Bioseparation Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Bioseparation Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Bioseparation Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceutical Bioseparation Systems Market

A strategic analysis of the Biopharmaceutical Bioseparation Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Bioseparation Systems Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Agilent Technologies, Inc., Alfa Wassermann, Inc., Asahi Kasei Medical Co., Ltd., Astrea Bioseparations Limited, Bio-Rad Laboratories, Inc., Danaher Corporation, Flottweg SE, GEA Group Aktiengesellschaft, GL Sciences Inc., Hitachi High-Tech Corporation., Jasco Pty Ltd., KNAUER Wissenschaftliche Gerate GmbH, Merck KGaA, Novasep Holding SAS, PerkinElmer Inc., Repligen Corporation, Restek Corporation, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Bioscience LLC, Waters Corporation, and YMC Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Bioseparation Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Cell Disruption Technology, Centrifuges Technology, Chromatography Technique, Electrophoresis, Extraction Technique, Filtration Technology, Membrane-based, and Precipitation.
  • Based on End-user, market is studied across Biopharmaceutical Companies and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for biopharmaceuticals and personalized medicines
      • 5.1.1.2. Government initiatives to boost domestic pharmaceutical industry
      • 5.1.1.3. Growing popularity and importance of targeted therapies
    • 5.1.2. Restraints
      • 5.1.2.1. High initial investments and operating costs of bioseparation equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing investments in bioseparation companies and technologies
      • 5.1.3.2. Rising advancements in biopharmaceutical separation technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory challenges and complex validation processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biopharmaceutical Bioseparation Systems Market, by Type

  • 6.1. Introduction
  • 6.2. Cell Disruption Technology
  • 6.3. Centrifuges Technology
  • 6.4. Chromatography Technique
  • 6.5. Electrophoresis
  • 6.6. Extraction Technique
  • 6.7. Filtration Technology
  • 6.8. Membrane-based
  • 6.9. Precipitation

7. Biopharmaceutical Bioseparation Systems Market, by End-user

  • 7.1. Introduction
  • 7.2. Biopharmaceutical Companies
  • 7.3. Research Institutes

8. Americas Biopharmaceutical Bioseparation Systems Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biopharmaceutical Bioseparation Systems Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biopharmaceutical Bioseparation Systems Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Agilent Technologies, Inc.
  • 3. Alfa Wassermann, Inc.
  • 4. Asahi Kasei Medical Co., Ltd.
  • 5. Astrea Bioseparations Limited
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Danaher Corporation
  • 8. Flottweg SE
  • 9. GEA Group Aktiengesellschaft
  • 10. GL Sciences Inc.
  • 11. Hitachi High-Tech Corporation.
  • 12. Jasco Pty Ltd.
  • 13. KNAUER Wissenschaftliche Gerate GmbH
  • 14. Merck KGaA
  • 15. Novasep Holding SAS
  • 16. PerkinElmer Inc.
  • 17. Repligen Corporation
  • 18. Restek Corporation
  • 19. Sartorius AG
  • 20. Shimadzu Corporation
  • 21. Thermo Fisher Scientific Inc.
  • 22. Tosoh Bioscience LLC
  • 23. Waters Corporation
  • 24. YMC Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CELL DISRUPTION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGES TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY EXTRACTION TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY FILTRATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023